Ignite Creation Date:
2024-05-06 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04688723
Status:
UNKNOWN
Last Update Posted:
2021-04-30
First Post:
2020-12-23
Brief Title:
Dual Therapy With DabigatranTicagrelor Versus Dual Therapy With DabigatranClopidogrel in ACS Patients With Indication for NOAC Undergoing PCI
Sponsor:
Zuyderland Medisch Centrum
Organization:
Zuyderland Medisch Centrum
Organization Data
Organization:
Zuyderland Medisch Centrum
Class:
OTHER
Study ID:
METCZ20200196
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zuyderland Medisch Centrum
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Boehringer Ingelheim | INDUSTRY |